"Opioid-Related Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders related or resulting from abuse or mis-use of opioids.
Descriptor ID |
D009293
|
MeSH Number(s) |
C25.775.675 F03.900.675
|
Concept/Terms |
Opioid-Related Disorders- Opioid-Related Disorders
- Disorder, Opioid-Related
- Opioid Abuse
- Abuse, Opioid
- Abuses, Opioid
- Opioid Abuses
- Opiate Abuse
- Abuse, Opiate
- Abuses, Opiate
- Opiate Abuses
Opiate Dependence- Opiate Dependence
- Dependence, Opiate
- Opiate Addiction
- Addiction, Opiate
|
Below are MeSH descriptors whose meaning is more general than "Opioid-Related Disorders".
Below are MeSH descriptors whose meaning is more specific than "Opioid-Related Disorders".
This graph shows the total number of publications written about "Opioid-Related Disorders" by people in this website by year, and whether "Opioid-Related Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 3 | 0 | 3 |
1995 | 2 | 1 | 3 |
1996 | 1 | 0 | 1 |
1997 | 4 | 1 | 5 |
1998 | 6 | 0 | 6 |
1999 | 2 | 0 | 2 |
2000 | 2 | 1 | 3 |
2001 | 3 | 0 | 3 |
2002 | 5 | 0 | 5 |
2003 | 2 | 1 | 3 |
2004 | 5 | 3 | 8 |
2005 | 5 | 1 | 6 |
2006 | 3 | 1 | 4 |
2007 | 2 | 4 | 6 |
2008 | 5 | 1 | 6 |
2009 | 4 | 1 | 5 |
2010 | 2 | 0 | 2 |
2011 | 2 | 0 | 2 |
2012 | 8 | 0 | 8 |
2013 | 3 | 4 | 7 |
2014 | 2 | 0 | 2 |
2015 | 6 | 2 | 8 |
2016 | 6 | 2 | 8 |
2017 | 6 | 1 | 7 |
2018 | 15 | 4 | 19 |
2019 | 13 | 4 | 17 |
2020 | 19 | 2 | 21 |
2021 | 18 | 1 | 19 |
2022 | 23 | 0 | 23 |
2023 | 15 | 0 | 15 |
2024 | 5 | 6 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Opioid-Related Disorders" by people in Profiles.
-
A genome-wide Association study of the Count of Codeine prescriptions. Sci Rep. 2024 10 01; 14(1):22780.
-
Patterns of gabapentinoid use among long-term opioid users. Prev Med. 2024 Aug; 185:108046.
-
Vaccines as Immunotherapies for Substance Use Disorders. Am J Psychiatry. 2024 May 01; 181(5):362-371.
-
96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial. Int J Drug Policy. 2024 May; 127:104390.
-
Provider perceptions of systems-level barriers and facilitators to utilizing family-based treatment approaches in adolescent and young adult opioid use disorder treatment. Addict Sci Clin Pract. 2024 03 21; 19(1):20.
-
Scheduled and Breakthrough Opioid Use for Cancer Pain in an Inpatient Setting at a Tertiary Cancer Hospital. Curr Oncol. 2024 03 05; 31(3):1335-1347.
-
Patients' willingness to pay for naloxone: A national cross-sectional survey of prescription opioid users with chronic pain in the United States. J Am Pharm Assoc (2003). 2024 May-Jun; 64(3):102062.
-
Psychedelic Therapy: A Primer for Primary Care Clinicians-Ibogaine. Am J Ther. 2024 Mar-Apr 01; 31(2):e133-e140.
-
Health utility among people who regularly use opioids in Australia. Drug Alcohol Rev. 2024 May; 43(4):997-1012.
-
Healthcare provider perceptions and reported practices regarding opioid prescription for patients with chronic cancer pain. Support Care Cancer. 2024 Jan 22; 32(2):121.